| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |